Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Soft Tissue Neoplasms | 14 | 2024 | 1156 | 3.620 |
Why?
|
Gastrointestinal Stromal Tumors | 14 | 2022 | 616 | 3.330 |
Why?
|
Sarcoma | 13 | 2022 | 1793 | 2.800 |
Why?
|
Gastrointestinal Neoplasms | 9 | 2023 | 953 | 2.210 |
Why?
|
Nerve Sheath Neoplasms | 4 | 2019 | 168 | 1.620 |
Why?
|
Immunohistochemistry | 26 | 2021 | 11070 | 1.330 |
Why?
|
Chromosome Aberrations | 10 | 2017 | 1771 | 1.300 |
Why?
|
Leiomyosarcoma | 5 | 2021 | 422 | 1.270 |
Why?
|
Neurilemmoma | 4 | 2019 | 525 | 1.240 |
Why?
|
Carcinosarcoma | 3 | 2012 | 105 | 1.120 |
Why?
|
Comparative Genomic Hybridization | 11 | 2017 | 473 | 1.040 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 5 | 2017 | 367 | 1.010 |
Why?
|
Thymus Neoplasms | 3 | 2023 | 273 | 0.930 |
Why?
|
Retinoblastoma Binding Proteins | 2 | 2021 | 101 | 0.850 |
Why?
|
Histones | 4 | 2020 | 2579 | 0.820 |
Why?
|
Chondroblastoma | 2 | 2020 | 48 | 0.780 |
Why?
|
Epithelioid Cells | 2 | 2019 | 60 | 0.760 |
Why?
|
Urachus | 2 | 2012 | 18 | 0.750 |
Why?
|
Heart Neoplasms | 2 | 2023 | 362 | 0.750 |
Why?
|
Neurofibromatosis 1 | 3 | 2015 | 560 | 0.740 |
Why?
|
Rhabdoid Tumor | 2 | 2020 | 210 | 0.700 |
Why?
|
Pheochromocytoma | 4 | 2021 | 328 | 0.700 |
Why?
|
Succinate Dehydrogenase | 2 | 2018 | 145 | 0.700 |
Why?
|
Uterine Neoplasms | 2 | 2021 | 1420 | 0.700 |
Why?
|
Chromosomal Proteins, Non-Histone | 4 | 2020 | 726 | 0.660 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.650 |
Why?
|
Stomach Neoplasms | 4 | 2014 | 1432 | 0.650 |
Why?
|
Genes, p53 | 1 | 2021 | 712 | 0.630 |
Why?
|
Gene Silencing | 3 | 2020 | 1509 | 0.610 |
Why?
|
Pleural Neoplasms | 1 | 2023 | 609 | 0.610 |
Why?
|
Mutation | 14 | 2023 | 30044 | 0.610 |
Why?
|
Bone Neoplasms | 3 | 2020 | 2527 | 0.600 |
Why?
|
Fumarate Hydratase | 1 | 2018 | 52 | 0.590 |
Why?
|
Chloride Channels | 1 | 2018 | 221 | 0.570 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2018 | 117 | 0.560 |
Why?
|
Transcription Factors | 8 | 2023 | 12122 | 0.560 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2017 | 696 | 0.560 |
Why?
|
Mesothelioma | 1 | 2023 | 807 | 0.560 |
Why?
|
Vascular Neoplasms | 1 | 2017 | 166 | 0.520 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2014 | 410 | 0.510 |
Why?
|
Adrenal Gland Neoplasms | 3 | 2021 | 732 | 0.500 |
Why?
|
In Situ Hybridization, Fluorescence | 8 | 2021 | 2509 | 0.480 |
Why?
|
Liver Neoplasms | 5 | 2023 | 4321 | 0.480 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 318 | 0.470 |
Why?
|
Costello Syndrome | 1 | 2014 | 19 | 0.460 |
Why?
|
Oncogene Proteins | 1 | 2018 | 718 | 0.460 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2014 | 55 | 0.460 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 227 | 0.450 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 1891 | 0.450 |
Why?
|
DNA Mutational Analysis | 11 | 2020 | 4108 | 0.450 |
Why?
|
Methylprednisolone | 2 | 2013 | 384 | 0.440 |
Why?
|
Cystic Duct | 1 | 2012 | 18 | 0.430 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2014 | 100 | 0.430 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2017 | 611 | 0.420 |
Why?
|
Trisomy | 1 | 2014 | 260 | 0.420 |
Why?
|
Pulmonary Blastoma | 1 | 2012 | 41 | 0.410 |
Why?
|
Neoplasm Invasiveness | 3 | 2019 | 3588 | 0.410 |
Why?
|
Splenic Neoplasms | 1 | 2013 | 94 | 0.410 |
Why?
|
Abdominal Neoplasms | 1 | 2014 | 287 | 0.410 |
Why?
|
Keratosis, Actinic | 1 | 2013 | 72 | 0.400 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2015 | 332 | 0.400 |
Why?
|
Umbilicus | 1 | 2012 | 36 | 0.390 |
Why?
|
Carcinoma, Basosquamous | 1 | 2011 | 7 | 0.380 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 938 | 0.380 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2013 | 178 | 0.380 |
Why?
|
Neoplasms, Vascular Tissue | 1 | 2011 | 25 | 0.380 |
Why?
|
Intestinal Neoplasms | 2 | 2012 | 311 | 0.380 |
Why?
|
DNA Methylation | 5 | 2017 | 4383 | 0.380 |
Why?
|
Medical Illustration | 1 | 2012 | 135 | 0.370 |
Why?
|
Nuclear Proteins | 4 | 2020 | 5794 | 0.370 |
Why?
|
Carcinoma, Basal Cell | 2 | 2019 | 560 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-kit | 4 | 2022 | 728 | 0.360 |
Why?
|
Glucose Transporter Type 1 | 1 | 2011 | 186 | 0.360 |
Why?
|
Spermatic Cord | 1 | 2010 | 23 | 0.360 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 694 | 0.360 |
Why?
|
Mediastinal Neoplasms | 1 | 2013 | 402 | 0.360 |
Why?
|
Teratoma | 1 | 2013 | 404 | 0.350 |
Why?
|
Humans | 87 | 2024 | 761326 | 0.350 |
Why?
|
Liposarcoma | 3 | 2018 | 285 | 0.350 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2010 | 82 | 0.340 |
Why?
|
Gastric Mucosa | 1 | 2012 | 601 | 0.340 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2013 | 339 | 0.330 |
Why?
|
Fibrosarcoma | 2 | 2024 | 308 | 0.330 |
Why?
|
Paraganglioma | 1 | 2010 | 142 | 0.320 |
Why?
|
Pulmonary Surfactants | 4 | 2012 | 162 | 0.320 |
Why?
|
Choristoma | 1 | 2010 | 206 | 0.310 |
Why?
|
Urination | 1 | 2010 | 203 | 0.310 |
Why?
|
Umbilical Cord | 1 | 2010 | 179 | 0.310 |
Why?
|
Diagnosis, Differential | 9 | 2018 | 12972 | 0.300 |
Why?
|
Arteries | 1 | 2013 | 1125 | 0.300 |
Why?
|
Ileum | 1 | 2010 | 557 | 0.300 |
Why?
|
Capillaries | 1 | 2011 | 755 | 0.300 |
Why?
|
DNA Helicases | 3 | 2020 | 851 | 0.290 |
Why?
|
Bile Duct Neoplasms | 1 | 2012 | 605 | 0.280 |
Why?
|
Middle Aged | 43 | 2024 | 220774 | 0.280 |
Why?
|
Suture Techniques | 1 | 2012 | 771 | 0.280 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 1742 | 0.280 |
Why?
|
Male | 54 | 2024 | 360621 | 0.280 |
Why?
|
Tumor Burden | 4 | 2018 | 1887 | 0.280 |
Why?
|
Spleen | 1 | 2013 | 2296 | 0.270 |
Why?
|
Edema | 2 | 2010 | 770 | 0.270 |
Why?
|
Antineoplastic Agents | 3 | 2022 | 13635 | 0.270 |
Why?
|
Cyclin-Dependent Kinase 4 | 3 | 2022 | 559 | 0.270 |
Why?
|
Stomach | 1 | 2010 | 694 | 0.260 |
Why?
|
Female | 44 | 2024 | 392485 | 0.250 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13333 | 0.250 |
Why?
|
Lipoma | 2 | 2018 | 292 | 0.250 |
Why?
|
Vascular Malformations | 1 | 2011 | 468 | 0.250 |
Why?
|
Adenoma | 2 | 2013 | 2159 | 0.250 |
Why?
|
Carcinoma | 1 | 2017 | 2328 | 0.250 |
Why?
|
Testicular Neoplasms | 1 | 2010 | 799 | 0.230 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2023 | 9275 | 0.220 |
Why?
|
Heredity | 2 | 2014 | 148 | 0.220 |
Why?
|
Aged | 26 | 2024 | 169179 | 0.220 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2821 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.200 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2022 | 184 | 0.200 |
Why?
|
Cell Proliferation | 2 | 2018 | 10431 | 0.200 |
Why?
|
Angiomyolipoma | 1 | 2023 | 186 | 0.200 |
Why?
|
Metanephrine | 1 | 2021 | 25 | 0.190 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2020 | 1605 | 0.190 |
Why?
|
Neoplasms | 2 | 2023 | 22158 | 0.190 |
Why?
|
Gene Rearrangement | 2 | 2018 | 1125 | 0.190 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2017 | 2911 | 0.180 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1647 | 0.180 |
Why?
|
Genes, p16 | 1 | 2021 | 159 | 0.180 |
Why?
|
Young Adult | 15 | 2024 | 59196 | 0.180 |
Why?
|
Biopsy | 6 | 2018 | 6768 | 0.180 |
Why?
|
Tropomyosin | 1 | 2020 | 104 | 0.180 |
Why?
|
Maxillary Neoplasms | 1 | 2020 | 47 | 0.170 |
Why?
|
Odontogenic Cysts | 1 | 2020 | 42 | 0.170 |
Why?
|
Dioxygenases | 1 | 2022 | 345 | 0.170 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 455 | 0.170 |
Why?
|
Necrosis | 2 | 2017 | 1605 | 0.170 |
Why?
|
Melanoma | 2 | 2015 | 5706 | 0.170 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4877 | 0.170 |
Why?
|
Odontogenic Tumors | 1 | 2020 | 45 | 0.170 |
Why?
|
Adult | 26 | 2024 | 221122 | 0.170 |
Why?
|
Sucrose | 1 | 2020 | 158 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2022 | 347 | 0.170 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2021 | 123 | 0.160 |
Why?
|
Prognosis | 9 | 2018 | 29588 | 0.160 |
Why?
|
Mandibular Neoplasms | 1 | 2020 | 130 | 0.160 |
Why?
|
Reperfusion Injury | 3 | 2012 | 1023 | 0.160 |
Why?
|
DNA-Binding Proteins | 5 | 2022 | 9605 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2011 | 4022 | 0.150 |
Why?
|
Pulmonary Edema | 1 | 2021 | 409 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2020 | 3638 | 0.150 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2010 | 2210 | 0.150 |
Why?
|
Histoplasmosis | 1 | 2018 | 63 | 0.150 |
Why?
|
Technology | 1 | 2020 | 292 | 0.150 |
Why?
|
Molecular Biology | 1 | 2021 | 579 | 0.150 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14665 | 0.140 |
Why?
|
Antigens, CD34 | 2 | 2017 | 658 | 0.140 |
Why?
|
Myoma | 1 | 2017 | 6 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 52 | 0.140 |
Why?
|
Succinic Acid | 1 | 2018 | 86 | 0.140 |
Why?
|
Lung | 5 | 2021 | 9994 | 0.140 |
Why?
|
Fumarates | 1 | 2018 | 131 | 0.140 |
Why?
|
Respiratory System | 1 | 2020 | 563 | 0.140 |
Why?
|
Mixed Function Oxygenases | 1 | 2018 | 266 | 0.140 |
Why?
|
Hypertension | 4 | 2021 | 8539 | 0.140 |
Why?
|
HMGA2 Protein | 1 | 2017 | 102 | 0.140 |
Why?
|
Autopsy | 1 | 2020 | 1006 | 0.130 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 287 | 0.130 |
Why?
|
Fatal Outcome | 3 | 2021 | 1833 | 0.130 |
Why?
|
Glutarates | 1 | 2018 | 243 | 0.130 |
Why?
|
World Health Organization | 1 | 2022 | 1320 | 0.130 |
Why?
|
Pedigree | 2 | 2014 | 4589 | 0.130 |
Why?
|
Solitary Fibrous Tumors | 1 | 2016 | 67 | 0.130 |
Why?
|
Infarction | 1 | 2017 | 248 | 0.130 |
Why?
|
Neurofibromin 1 | 1 | 2017 | 190 | 0.130 |
Why?
|
Thymoma | 1 | 2017 | 187 | 0.120 |
Why?
|
Gout | 1 | 2022 | 623 | 0.120 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1114 | 0.120 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2015 | 67 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2018 | 367 | 0.120 |
Why?
|
Aged, 80 and over | 11 | 2020 | 58946 | 0.120 |
Why?
|
Desmin | 1 | 2014 | 99 | 0.120 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2014 | 45 | 0.120 |
Why?
|
Chondroma | 1 | 2014 | 53 | 0.120 |
Why?
|
Germany | 2 | 2015 | 875 | 0.120 |
Why?
|
Hutchinson's Melanotic Freckle | 1 | 2013 | 25 | 0.110 |
Why?
|
Mechanoreceptors | 1 | 2015 | 188 | 0.110 |
Why?
|
Adolescent | 11 | 2024 | 88305 | 0.110 |
Why?
|
Mycetoma | 1 | 2013 | 18 | 0.110 |
Why?
|
Lung Abscess | 1 | 2013 | 40 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 2 | 2018 | 4509 | 0.110 |
Why?
|
Intestinal Polyps | 1 | 2014 | 104 | 0.110 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2021 | 1384 | 0.110 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2013 | 74 | 0.110 |
Why?
|
Leukemia, B-Cell | 1 | 2013 | 84 | 0.110 |
Why?
|
Antibodies, Monoclonal | 3 | 2018 | 9180 | 0.110 |
Why?
|
Hyalin | 1 | 2013 | 34 | 0.110 |
Why?
|
Pulmonary Aspergillosis | 1 | 2013 | 47 | 0.110 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2014 | 232 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4567 | 0.110 |
Why?
|
Biopsy, Fine-Needle | 1 | 2018 | 1118 | 0.110 |
Why?
|
Cystadenoma | 1 | 2013 | 79 | 0.100 |
Why?
|
Receptors, Estrogen | 1 | 2021 | 2208 | 0.100 |
Why?
|
RNA-Binding Protein EWS | 1 | 2014 | 210 | 0.100 |
Why?
|
Child, Preschool | 4 | 2021 | 42251 | 0.100 |
Why?
|
Adenocarcinoma | 1 | 2010 | 6332 | 0.100 |
Why?
|
Osteopontin | 1 | 2014 | 301 | 0.100 |
Why?
|
Digestive System Surgical Procedures | 2 | 2015 | 573 | 0.100 |
Why?
|
Brain Neoplasms | 2 | 2011 | 9030 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 5 | 2020 | 17872 | 0.100 |
Why?
|
Cell Shape | 1 | 2013 | 371 | 0.100 |
Why?
|
Chromosome Deletion | 1 | 2017 | 1387 | 0.100 |
Why?
|
Phenotype | 4 | 2020 | 16603 | 0.100 |
Why?
|
Parotid Gland | 1 | 2013 | 175 | 0.100 |
Why?
|
Blood-Air Barrier | 2 | 2012 | 24 | 0.100 |
Why?
|
Neoplasm, Residual | 1 | 2017 | 1008 | 0.100 |
Why?
|
Radiation Injuries, Experimental | 1 | 2011 | 88 | 0.100 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6815 | 0.100 |
Why?
|
Temporal Arteries | 1 | 2013 | 154 | 0.100 |
Why?
|
Organ Preservation Solutions | 1 | 2012 | 100 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6473 | 0.090 |
Why?
|
Telomerase | 1 | 2016 | 745 | 0.090 |
Why?
|
Splenectomy | 1 | 2013 | 391 | 0.090 |
Why?
|
Parotid Neoplasms | 1 | 2013 | 157 | 0.090 |
Why?
|
Pinealoma | 1 | 2011 | 52 | 0.090 |
Why?
|
Heart Arrest | 1 | 2021 | 1514 | 0.090 |
Why?
|
Cholecystolithiasis | 1 | 2010 | 7 | 0.090 |
Why?
|
Primary Graft Dysfunction | 1 | 2012 | 111 | 0.090 |
Why?
|
Diverticulosis, Colonic | 1 | 2010 | 9 | 0.090 |
Why?
|
Opportunistic Infections | 1 | 2013 | 376 | 0.090 |
Why?
|
Hemangioendothelioma | 1 | 2011 | 111 | 0.090 |
Why?
|
Leiomyoma | 1 | 2015 | 636 | 0.090 |
Why?
|
Aneurysm, False | 1 | 2013 | 254 | 0.090 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2011 | 310 | 0.090 |
Why?
|
Pineal Gland | 1 | 2011 | 158 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3777 | 0.090 |
Why?
|
Mitosis | 1 | 2015 | 1186 | 0.090 |
Why?
|
Treatment Outcome | 7 | 2017 | 64645 | 0.090 |
Why?
|
Thigh | 1 | 2011 | 241 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15262 | 0.090 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2011 | 313 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39108 | 0.080 |
Why?
|
Fibrosis | 1 | 2017 | 2048 | 0.080 |
Why?
|
Time Factors | 3 | 2017 | 39974 | 0.080 |
Why?
|
Connective Tissue | 2 | 2022 | 419 | 0.080 |
Why?
|
Cryptorchidism | 1 | 2010 | 151 | 0.080 |
Why?
|
Mucin-1 | 1 | 2014 | 539 | 0.080 |
Why?
|
Chromosomal Instability | 1 | 2010 | 178 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 2 | 2010 | 1809 | 0.080 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2010 | 101 | 0.080 |
Why?
|
Surface-Active Agents | 1 | 2009 | 149 | 0.080 |
Why?
|
Pseudomonas Infections | 1 | 2013 | 623 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1053 | 0.080 |
Why?
|
Karyotyping | 1 | 2010 | 1171 | 0.080 |
Why?
|
Duodenum | 1 | 2012 | 489 | 0.080 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4908 | 0.080 |
Why?
|
Cell Cycle | 1 | 2017 | 2930 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5665 | 0.080 |
Why?
|
Organ Preservation | 1 | 2012 | 382 | 0.080 |
Why?
|
Gastritis | 1 | 2010 | 199 | 0.080 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2013 | 491 | 0.080 |
Why?
|
Myocardium | 1 | 2021 | 4723 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2017 | 6086 | 0.080 |
Why?
|
Antirheumatic Agents | 1 | 2018 | 1371 | 0.080 |
Why?
|
Consensus | 3 | 2022 | 3122 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 5 | 2014 | 36430 | 0.080 |
Why?
|
Drug Therapy, Combination | 3 | 2013 | 6309 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2016 | 5778 | 0.070 |
Why?
|
Lung Injury | 2 | 2009 | 422 | 0.070 |
Why?
|
Neuroendocrine Tumors | 1 | 2014 | 642 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 6 | 2013 | 20555 | 0.070 |
Why?
|
Hepatectomy | 1 | 2011 | 558 | 0.070 |
Why?
|
Fatty Liver | 2 | 2011 | 788 | 0.070 |
Why?
|
Interferon-alpha | 1 | 2011 | 921 | 0.070 |
Why?
|
Heterozygote | 1 | 2014 | 2803 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2022 | 5297 | 0.070 |
Why?
|
Cell Survival | 1 | 2017 | 5792 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 3448 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4740 | 0.070 |
Why?
|
Aortic Aneurysm | 1 | 2011 | 648 | 0.070 |
Why?
|
Hematoma | 1 | 2011 | 768 | 0.070 |
Why?
|
Mitochondria, Heart | 1 | 2007 | 229 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2012 | 1121 | 0.070 |
Why?
|
Prostatic Hyperplasia | 1 | 2010 | 521 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3611 | 0.070 |
Why?
|
Intestine, Small | 1 | 2012 | 1205 | 0.070 |
Why?
|
Vocal Cords | 1 | 2010 | 522 | 0.060 |
Why?
|
Pseudomonas aeruginosa | 1 | 2013 | 1279 | 0.060 |
Why?
|
Lower Extremity | 1 | 2013 | 1201 | 0.060 |
Why?
|
Lymphoma, B-Cell | 1 | 2012 | 940 | 0.060 |
Why?
|
Steroids | 1 | 2010 | 928 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2014 | 3512 | 0.060 |
Why?
|
Aortic Diseases | 1 | 2011 | 737 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12450 | 0.060 |
Why?
|
Actins | 1 | 2013 | 2051 | 0.060 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 791 | 0.060 |
Why?
|
Germ-Line Mutation | 1 | 2013 | 1858 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2014 | 1897 | 0.060 |
Why?
|
Lung Transplantation | 2 | 2012 | 1309 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2012 | 1116 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 1 | 2017 | 3396 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2013 | 2009 | 0.060 |
Why?
|
Drug Resistance | 1 | 2010 | 1597 | 0.060 |
Why?
|
Radiography, Thoracic | 2 | 2021 | 1303 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2013 | 1157 | 0.060 |
Why?
|
Hepacivirus | 1 | 2011 | 1337 | 0.060 |
Why?
|
Child | 5 | 2021 | 80156 | 0.060 |
Why?
|
Physical Conditioning, Animal | 1 | 2007 | 365 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2013 | 2650 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2811 | 0.050 |
Why?
|
Cerebrovascular Disorders | 1 | 2010 | 1475 | 0.050 |
Why?
|
Hepatitis C, Chronic | 1 | 2011 | 1032 | 0.050 |
Why?
|
Indazoles | 1 | 2024 | 302 | 0.050 |
Why?
|
Intestines | 1 | 2011 | 1909 | 0.050 |
Why?
|
Ultrasonography | 2 | 2013 | 5970 | 0.050 |
Why?
|
Biological Products | 1 | 2012 | 913 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 1 | 2018 | 3760 | 0.050 |
Why?
|
Anthracyclines | 1 | 2024 | 284 | 0.050 |
Why?
|
Neoplasms, Second Primary | 1 | 2010 | 1051 | 0.050 |
Why?
|
Cardiopulmonary Bypass | 1 | 2007 | 1094 | 0.050 |
Why?
|
Ultrasonography, Prenatal | 1 | 2010 | 1755 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1405 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2534 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8527 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 13355 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3538 | 0.050 |
Why?
|
Radiography | 1 | 2011 | 6966 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8635 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5820 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2024 | 875 | 0.040 |
Why?
|
Disease Progression | 1 | 2017 | 13500 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2093 | 0.040 |
Why?
|
Receptor, trkA | 1 | 2020 | 159 | 0.040 |
Why?
|
CpG Islands | 2 | 2014 | 1225 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4936 | 0.040 |
Why?
|
Liver | 2 | 2011 | 7531 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2011 | 3057 | 0.040 |
Why?
|
Anxiety Disorders | 1 | 2010 | 2717 | 0.040 |
Why?
|
Tachycardia | 1 | 2021 | 600 | 0.040 |
Why?
|
Myocytes, Cardiac | 1 | 2007 | 1671 | 0.040 |
Why?
|
Colitis, Ulcerative | 1 | 2010 | 1922 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9414 | 0.040 |
Why?
|
Histoplasma | 1 | 2018 | 39 | 0.040 |
Why?
|
Animals | 9 | 2022 | 168388 | 0.040 |
Why?
|
Postoperative Complications | 3 | 2021 | 15647 | 0.040 |
Why?
|
Electrocardiography | 2 | 2021 | 6382 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4173 | 0.040 |
Why?
|
Gene Fusion | 1 | 2020 | 356 | 0.040 |
Why?
|
Inflammasomes | 1 | 2022 | 525 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7852 | 0.040 |
Why?
|
Remission Induction | 2 | 2013 | 2395 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2022 | 997 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2014 | 5363 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 808 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2010 | 12144 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2010 | 2891 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 682 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15719 | 0.030 |
Why?
|
Pneumonia | 1 | 2007 | 2140 | 0.030 |
Why?
|
Shock, Cardiogenic | 1 | 2021 | 709 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2007 | 3816 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2010 | 4236 | 0.030 |
Why?
|
Microscopy, Electron | 2 | 2008 | 2560 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 3 | 2012 | 8166 | 0.030 |
Why?
|
Sulfonamides | 1 | 2024 | 1976 | 0.030 |
Why?
|
Echocardiography | 2 | 2021 | 4991 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2022 | 2137 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23427 | 0.030 |
Why?
|
Rats | 4 | 2012 | 23729 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2024 | 80575 | 0.030 |
Why?
|
Macrophages | 2 | 2023 | 5768 | 0.030 |
Why?
|
CHARGE Syndrome | 1 | 2012 | 33 | 0.030 |
Why?
|
Random Allocation | 2 | 2007 | 2389 | 0.030 |
Why?
|
Colon, Sigmoid | 1 | 2013 | 124 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 282 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3025 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11735 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2013 | 198 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2017 | 1745 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 550 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2017 | 1393 | 0.020 |
Why?
|
Capsule Endoscopy | 1 | 2012 | 100 | 0.020 |
Why?
|
gamma-Glutamyltransferase | 1 | 2011 | 144 | 0.020 |
Why?
|
Tomography, Spiral Computed | 1 | 2013 | 273 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2012 | 698 | 0.020 |
Why?
|
Epigenesis, Genetic | 2 | 2014 | 3793 | 0.020 |
Why?
|
Mucositis | 1 | 2011 | 108 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2010 | 6392 | 0.020 |
Why?
|
Hyperplasia | 1 | 2014 | 1153 | 0.020 |
Why?
|
Depression | 1 | 2010 | 8122 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3873 | 0.020 |
Why?
|
Survival Rate | 2 | 2014 | 12710 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5034 | 0.020 |
Why?
|
Granulocytes | 1 | 2011 | 552 | 0.020 |
Why?
|
Ribavirin | 1 | 2011 | 395 | 0.020 |
Why?
|
Infant | 1 | 2012 | 36202 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2010 | 26211 | 0.020 |
Why?
|
Tunica Intima | 1 | 2011 | 459 | 0.020 |
Why?
|
Risk Factors | 2 | 2014 | 74152 | 0.020 |
Why?
|
Vincristine | 1 | 2011 | 1036 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2011 | 605 | 0.020 |
Why?
|
Ventricular Fibrillation | 1 | 2011 | 537 | 0.020 |
Why?
|
Citrates | 1 | 2008 | 135 | 0.020 |
Why?
|
Genotype | 2 | 2014 | 12982 | 0.020 |
Why?
|
Immune System | 1 | 2013 | 794 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2011 | 1846 | 0.020 |
Why?
|
Obesity | 1 | 2010 | 12934 | 0.020 |
Why?
|
Organ Specificity | 1 | 2012 | 1967 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 29858 | 0.020 |
Why?
|
Volition | 1 | 2007 | 62 | 0.020 |
Why?
|
Chemokines | 1 | 2011 | 960 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 5497 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4175 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54405 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 1682 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 1967 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2913 | 0.020 |
Why?
|
Prednisone | 1 | 2011 | 1564 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2009 | 650 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 696 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3097 | 0.020 |
Why?
|
Blood Vessel Prosthesis | 1 | 2011 | 954 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2012 | 18234 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2392 | 0.020 |
Why?
|
Ventricular Function | 1 | 2007 | 406 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2011 | 2218 | 0.020 |
Why?
|
Central Nervous System | 1 | 2012 | 1337 | 0.020 |
Why?
|
Doxorubicin | 1 | 2011 | 2215 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10075 | 0.010 |
Why?
|
Mice | 3 | 2022 | 81474 | 0.010 |
Why?
|
Chest Pain | 1 | 2011 | 1090 | 0.010 |
Why?
|
Radiotherapy | 1 | 2011 | 1499 | 0.010 |
Why?
|
Perfusion | 1 | 2008 | 1374 | 0.010 |
Why?
|
Aorta | 1 | 2011 | 2042 | 0.010 |
Why?
|
Antigens, CD | 1 | 2013 | 4000 | 0.010 |
Why?
|
Running | 1 | 2007 | 488 | 0.010 |
Why?
|
Societies, Medical | 1 | 2015 | 3905 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21336 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2252 | 0.010 |
Why?
|
Colonoscopy | 1 | 2010 | 1394 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4810 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6525 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2012 | 3612 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4423 | 0.010 |
Why?
|
Patient Selection | 1 | 2013 | 4244 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2007 | 2358 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3027 | 0.010 |
Why?
|
Base Sequence | 1 | 2011 | 12449 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9351 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2011 | 2071 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7582 | 0.010 |
Why?
|
Ischemia | 1 | 2008 | 1876 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 3356 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8470 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4063 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8526 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17640 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7597 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11098 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2009 | 3666 | 0.010 |
Why?
|
Sepsis | 1 | 2011 | 2587 | 0.010 |
Why?
|
Swine | 1 | 2007 | 5915 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2013 | 6478 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4355 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20092 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18401 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2011 | 10191 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10760 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15879 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22154 | 0.010 |
Why?
|